149 related articles for article (PubMed ID: 36350264)
1. Platelet-Covered Nanocarriers for Targeted Delivery of Hirudin to Eliminate Thrombotic Complication in Tumor Therapy.
Zhang K; Ma Z; Li S; Zhang W; Foda MF; Zhao Y; Han H
ACS Nano; 2022 Nov; 16(11):18483-18496. PubMed ID: 36350264
[TBL] [Abstract][Full Text] [Related]
2. Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin.
Mruk JS; Zoldhelyi P; Webster MW; Heras M; Grill DE; Holmes DR; Fuster V; Chesebro JH
Circulation; 1996 Feb; 93(4):792-9. PubMed ID: 8641009
[TBL] [Abstract][Full Text] [Related]
3. Self-regulated hirudin delivery for anticoagulant therapy.
Xu X; Huang X; Zhang Y; Shen S; Feng Z; Dong H; Zhang C; Mo R
Sci Adv; 2020 Oct; 6(41):. PubMed ID: 33036973
[TBL] [Abstract][Full Text] [Related]
4. Hirudin interruption of heparin-resistant arterial thrombus formation in baboons.
Kelly AB; Marzec UM; Krupski W; Bass A; Cadroy Y; Hanson SR; Harker LA
Blood; 1991 Mar; 77(5):1006-12. PubMed ID: 1995089
[TBL] [Abstract][Full Text] [Related]
5. Local delivery of r-hirudin by a double-balloon perfusion catheter prevents mural thrombosis and minimizes platelet deposition after angioplasty.
Meyer BJ; Fernández-Ortiz A; Mailhac A; Falk E; Badimon L; Michael AD; Chesebro JH; Fuster V; Badimon JJ
Circulation; 1994 Nov; 90(5):2474-80. PubMed ID: 7955205
[TBL] [Abstract][Full Text] [Related]
6. Thrombin regulation of platelet interaction with damaged vessel wall and isolated collagen type I at arterial flow conditions in a porcine model: effects of hirudins, heparin, and calcium chelation.
Badimon L; Badimon JJ; Lassila R; Heras M; Chesebro JH; Fuster V
Blood; 1991 Jul; 78(2):423-34. PubMed ID: 2070078
[TBL] [Abstract][Full Text] [Related]
7. r-Hirudin inhibits platelet-dependent thrombosis during cardiopulmonary bypass in baboons.
van Wyk V; Neethling WM; Badenhorst PN; Kotzé HF
J Cardiovasc Surg (Torino); 1998 Oct; 39(5):633-9. PubMed ID: 9833724
[TBL] [Abstract][Full Text] [Related]
8. Dissolution of mural thrombus by specific thrombin inhibition with r-hirudin: comparison with heparin and aspirin.
Meyer BJ; Badimon JJ; Chesebro JH; Fallon JT; Fuster V; Badimon L
Circulation; 1998 Feb; 97(7):681-5. PubMed ID: 9495304
[TBL] [Abstract][Full Text] [Related]
9. Recombinant hirudin as an anticoagulant during cardiac operations: experiments in a pig model.
Riess FC; Pötzsch B; Behr I; Jäger K; Rössing R; Bleese N; Schaper W; Müller-Berghaus G
Eur J Cardiothorac Surg; 1997 Apr; 11(4):739-45. PubMed ID: 9151047
[TBL] [Abstract][Full Text] [Related]
10. The antithrombotic effect of a novel hirudin derivative after reconstruction of carotid artery in rabbits.
Lu WF; Mo W; Liu Z; Fu WG; Guo DQ; Wang YQ; Song HY
Thromb Res; 2010 Oct; 126(4):e339-43. PubMed ID: 20483158
[TBL] [Abstract][Full Text] [Related]
11. Platelet functions in recombinant hirudin-anticoagulated blood.
Glusa E; Markwardt F
Haemostasis; 1990; 20(2):112-8. PubMed ID: 2363746
[TBL] [Abstract][Full Text] [Related]
12. Antithrombin is as effective as heparin and hirudin to prevent formation of microvascular thrombosis in a murine model.
Sorg H; Hoffmann JN; Menger MD; Lindenblatt N; Goehring P; Vollmar B
Thromb Haemost; 2006 Sep; 96(3):371-7. PubMed ID: 16953281
[TBL] [Abstract][Full Text] [Related]
13. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
[TBL] [Abstract][Full Text] [Related]
14. Hirudin, heparin, and placebo during deep arterial injury in the pig. The in vivo role of thrombin in platelet-mediated thrombosis.
Heras M; Chesebro JH; Webster MW; Mruk JS; Grill DE; Penny WJ; Bowie EJ; Badimon L; Fuster V
Circulation; 1990 Oct; 82(4):1476-84. PubMed ID: 2401076
[TBL] [Abstract][Full Text] [Related]
15. Biomimetic Nanoplatelets to Target Delivery Hirudin for Site-Specific Photothermal/Photodynamic Thrombolysis and Preventing Venous Thrombus Formation.
Li S; Zhang K; Ma Z; Zhang W; Song Z; Wang W; Han H
Small; 2022 Dec; 18(51):e2203184. PubMed ID: 36344452
[TBL] [Abstract][Full Text] [Related]
16. Use of recombinant hirudin in heparin-induced thrombocytopenia and thrombosis (HITT) and renal failure--a case report.
Whelen S; Carr ME
Angiology; 2001 Oct; 52(10):711-5. PubMed ID: 11666136
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Multiplate platelet aggregometry using citrate, heparin or hirudin in Rhesus macaques.
Dugan G; O'Donnell L; Hanbury DB; Cline JM; Caudell DL
Platelets; 2015; 26(8):730-5. PubMed ID: 25549285
[TBL] [Abstract][Full Text] [Related]
18. Improving long circulation and procoagulant platelet targeting by engineering of hirudin prodrug.
Han HH; Zhang HT; Wang R; Yan Y; Liu X; Wang Y; Zhu Y; Wang JC
Int J Pharm; 2020 Nov; 589():119869. PubMed ID: 32919000
[TBL] [Abstract][Full Text] [Related]
19. Direct thrombin inhibitors for treatment of arterial thrombosis: potential differences between bivalirudin and hirudin.
Bates SM; Weitz JI
Am J Cardiol; 1998 Oct; 82(8B):12P-18P. PubMed ID: 9809887
[TBL] [Abstract][Full Text] [Related]
20. Engineering a "three-in-one" hirudin prodrug to reduce bleeding risk: A proof-of-concept study.
Zhu Y; Han HH; Zhai L; Yan Y; Liu X; Wang Y; Lei L; Wang JC
J Control Release; 2021 Oct; 338():462-471. PubMed ID: 34481024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
